MedBioinformatics Solutions SL has its foundations in the ten years of work of researchers from the Research Programme on Biomedical Informatics (GRIB) from the Hospital del Mar Medical Research Institute (IMIM) and the Pompeu Fabra University (UPF).
The company aims to exploit biomedical data to support drug discovery pipelines and to enhance biomedical research. Our company is based on three pillars: expertise in life sciences, cutting edge methods of artificial intelligence, and vast experience at tackling a variety of biomedical questions.
Nearly all human diseases have a genetic component.
During the last 25 years, we have witnessed an unprecedented progress in the discovery of genetic variation associated with diseases. New possibilities of using this information to improve disease diagnosis, develop new treatments or predict individual susceptibility to diseases have emerged.